Gilead Sciences · 4 hours ago
Exec Director, Asset Team Leader - Liver
San Francisco Bay Area
Full-time
Onsite
Director/Executive
$302K/yr - $391K/yr
14+ years expGilead Sciences is dedicated to creating a healthier world by tackling major diseases and developing life-changing therapies. The Exec Director, Asset Team Leader will lead cross-functional asset teams, shape strategic direction, and ensure optimal program execution for assets related to liver diseases.
BiopharmaBiotechnologyHealth CareManufacturingPharmaceutical
Responsibilities
Lead Gilead asset teams in developing and executing cohesive asset and program strategies, ensuring alignment with Gilead’s broader organizational goals through effective resource assessment, timeline management, and risk mitigation
Enable strong collaboration around a shared asset vision, ensuring transparent and effective flow of asset‑related information and decisions across teams and partners
Assume responsibility for the timely achievement of key asset-related milestones
Develop and present comprehensive global asset strategies encompassing product development, manufacturing, commercialization and lifecycle management, adapting plans as clinical, regulatory, or commercial landscapes evolve
Act as decision facilitator, incorporating cross-functional insights to resolve high-impact issues, drive scenario planning and risk analysis, and communicate transparently with senior leadership and governance bodies
Align cross‑functional teams around a unified asset vision, fostering clarity of roles and accountability, and cultivating a high‑performing, inclusive and collaborative team environment that drives productive debate, cohesive strategy execution and decision‑making
Build and maintain strong relationships with internal and external partners to support program success and innovation
Ensure excellence in operationalization of integrated asset strategy and stakeholder activities according to strategic directives to deliver on program milestones
Effectively articulate and champion asset strategies, scientific rationale, and clinical objectives to diverse audiences, supporting Gilead’s reputation and mission
Collaborate with Therapeutic Area Leaders and Business Development to advise on disease area strategies for discovery, innovation, development, and lifecycle planning
Qualification
Required
Advanced scientific, medical, or commercial background with expertise in drug development and relevant therapeutic areas, and proven ability to make complex decisions with an enterprise perspective
Demonstrated cross-functional leadership across global initiatives, effectively managing projects and executing strategic plans
Proven ability to lead multidisciplinary teams and integrate discovery, development, regulatory, and commercial considerations across all asset lifecycle phases
Able to lead, influence, and deliver significant impact even in the absence of direct authority
Exceptional communication, organizational, and decision-making skills, able to resolve complex issues and influence senior leaders
Track record of high-level performance and strategic value delivery within global pharmaceutical or biotech organizations
Comprehensive understanding of the drug development process, including full asset lifecycle management and end-to-end brand exposure
Bachelor's degree in a scientific or business discipline required
Minimum Experience requirements for Executive Director Level: 16+ with BS; 14+ MS or PhD; 8+ years with MD
Preferred
Advanced degrees such as PhD, MD, or MBA highly preferred
12+ years' biopharmaceutical industry experience preferred, with at least 8 years in relevant roles within biotech/pharmaceutical organizations
Comprehensive knowledge of the overall drug development process, with experience in commercial launches and program/asset strategy teams strongly desired
Benefits
Discretionary annual bonus
Discretionary stock-based long-term incentives (eligibility may vary based on role)
Paid time off
Company-sponsored medical, dental, vision, and life insurance plans
Company
Gilead Sciences
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.
10001+ employees
H1B Sponsorship
Gilead Sciences has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (269)
2024 (241)
2023 (222)
2022 (208)
2021 (235)
2020 (187)
Funding
Current Stage
Public CompanyTotal Funding
$4.41BKey Investors
Abingworth
2024-11-13Post Ipo Debt· $3.5M
2024-02-29Post Ipo Equity· $210M
2023-09-07Post Ipo Debt· $2B
Leadership Team
Keeley Wettan
Senior Vice President, Legal
Patrick Loerch
Senior Vice President, Clinical Data Science
Recent News
2026-01-20
2026-01-16
Company data provided by crunchbase